New CEO has turned this previously dull company into a raging bull hitting new highs week after week. Looks like stock has enormous potential and could be a buy-out target for the larger pharms.
Price is up and that is great but why would large pharms buy FRX?? They dont have 1 product that makes a billion and also all the products are partnerships not owned
do they necessarily need one product that produces revenue of a billion to be bought out?